• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ardelyx Inc (NQ: ARDX )

    6.350 +0.300 (+4.96%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,015,388
    Open 6.040
    Bid (Size) 6.320 (1)
    Ask (Size) 6.380 (5)
    Prev. Close 6.050
    Today's Range 6.029 - 6.480
    52wk Range 3.160 - 10.13
    Shares Outstanding 103,119,010
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ardelyx, Inc. Investors Can Join the Class Action Lawsuit!
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire

    Performance

    YTD
    +4.96%
    +4.96%
    1 Month
    +12.99%
    +12.99%
    3 Month
    -5.93%
    -5.93%
    6 Month
    -26.84%
    -26.84%
    1 Year
    +80.91%
    +80.91%

    More News

    Read More
    ARDELYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    What 6 Analyst Ratings Have To Say About Ardelyx
    Via Benzinga
    Analyst Expectations For Ardelyx's Future
    Via Benzinga
    Ardelyx, Inc. Investor Notice: Robbins LLP Reminds Shareholders of the Pending ARDX Class Action
    From Robbins LLP
    Via Business Wire
    ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx
    From Faruqi & Faruqi, LLP
    Via Business Wire
    How Is The Market Feeling About Ardelyx?
    Via Benzinga
    What Analysts Are Saying About Ardelyx Stock
    Via Benzinga
    Rosen Law Firm Urges Ardelyx, Inc. (NASDAQ: ARDX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    Stockholder Alert: Robbins LLP Informs Ardelyx, Inc. Stockholders of the Class Action Against ARDX
    From Robbins LLP
    Via GlobeNewswire
    Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
    From Ardelyx, Inc.
    Via GlobeNewswire
    Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
    From Ardelyx, Inc.
    Via GlobeNewswire
    Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
    From Ardelyx, Inc.
    Via GlobeNewswire
    Get Your Money Out of These 3 Biotech Stocks Before the End of July
    Via InvestorPlace
    Ardelyx Files Lawsuit Over Medicare Drug Payment Rules, Claims It Will Limit Patient Access To Kidney Disease Treatment
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
    From Ardelyx, Inc.
    Via GlobeNewswire
    Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
    From Ardelyx, Inc.
    Via GlobeNewswire
    Why Ardelyx Stock Is Dropping
    Via Benzinga
    To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
    From Ardelyx, Inc.
    Via GlobeNewswire
    Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
    From Ardelyx, Inc.
    Via GlobeNewswire
    3 Stocks Under $10 With the Potential to Make You a Millionaire
    Via InvestorPlace
    Ardelyx, Inc. Reports Employment Inducement Grants
    From Ardelyx, Inc.
    Via GlobeNewswire
    Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.